Evidence map›Paper›PMID 39129889›Full record

ArticleJournal of the Society for Cardiovascular Angiography & Interventions

Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes.

Jennifer Frampton, Kathleen E Kearney, J Dawn Abbott, Dean J Kereiakes, Carlo Di Mario, Shigeru Saito, Ecaterina Cristea, Robert F Riley, Jean Fajadet, Richard A Shlofmitz and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of the Society for Cardiovascular Angiography & Interventions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Jennifer FramptonSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Kathleen E KearneyUniversity of Washington, Seattle, Washington.
J Dawn AbbottLifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Dean J KereiakesThe Christ Hospital and the Lindner Research Center, Cincinnati, Ohio.
Carlo Di MarioCareggi University Hospital, Florence, Italy.
Shigeru SaitoShonan-Kamakura General Hospital, Kamakura, Kanagawa, Japan.
Ecaterina CristeaSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Robert F RileyOverlake Medical Center & Clinics, Bellevue, Washington.
Jean FajadetClinique Pasteur, Toulouse, France.
Richard A ShlofmitzSt. Francis Hospital, Roslyn, New York.
Ziad A AliCardiovascular Research Foundation, New York, New York.
Andrew J KleinPiedmont Heart Interventional Cardiology, Atlanta, Georgia.
Matthew J PriceScripps Clinic, La Jolla, California.
Jonathan M HillRoyal Brompton Hospital, London, United Kingdom.
Gregg W StoneThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Alexandra J LanskySection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intravascular lithotripsy (IVL) for calcified lesion preparation prior to drug-eluting stent placement has high procedural success and safety, especially in women, whereas other atheroablative approaches are associated with increased procedural complications. We sought to investigate long-term sex-based outcomes of IVL-facilitated stenting. Methods: We performed a patient-level pooled analysis of the single-arm Disrupt CAD III and IV studies. Patient baseline, procedural characteristics, and outcomes were examined according to sex at 30 days and 1 year. The primary end point was major adverse cardiac events (a composite of cardiac death, all myocardial infarction, or target vessel revascularization). Target lesion failure was defined as cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization. Results: A total of 448 patients, 106 (24%) women, were included. Women were older and less likely to be smokers. Women had smaller reference vessel diameters (2.8 mm vs 3.1 mm), shorter lesion length (23.6 mm vs 27.1 mm), and shorter total calcified length (44.4 mm vs 49.3 mm) compared with men. Post-IVL angiographic outcomes and complications were similar between women and men. At 1 year, major adverse cardiac event rates (12.3% vs 13.2%, Conclusions: Use of IVL in the treatment of severely calcified lesions is associated with low rates of adverse clinical events and with similar safety and effectiveness in women and men at 1 year.

Indexed as

calcificationcoronary artery diseasedrug-eluting stentintravascular lithotripsysex

Identifiers

PMID39129889
PMCPMC11307843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.